{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:29:53Z","timestamp":1790022593869,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.gastrohep.2022.02.002","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T11:14:44Z","timestamp":1645182884000},"page":"767-779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evoluci\u00f3n de los pacientes con infecci\u00f3n cr\u00f3nica por hepatitis C con fibrosis avanzada o cirrosis curados con antivirales de acci\u00f3n directa. Seguimiento a largo plazo"],"prefix":"10.1016","volume":"45","author":[{"given":"Ester","family":"Badia Aranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Fern\u00e1ndez Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Puebla Maestu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Visitaci\u00f3n","family":"Gozalo Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Vinuesa Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Calvo Simal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"G\u00f3mez Camarero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastrohep.2022.02.002_bib0155","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0160","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bpg.2012.09.009","article-title":"Natural history of acute and chronic hepatitisC","volume":"26","author":"Maasoumy","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0165","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/cid\/civ396","article-title":"Long-term treatment outcomes of patients infected with hepatitisC virus: A systematic review and meta-analysis of the survival benefit of achieving a sustained virological response","volume":"61","author":"Simmons","year":"2015","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0170","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1055\/s-0039-1685538","article-title":"Long-term impact of direct-acting antiviral agent therapy in HCV cirrhosis: Critical review","volume":"39","author":"Fehily","year":"2019","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0175","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.cgh.2011.03.004","article-title":"A sustained virologic response reduces risk of all-cause mortality in patients with hepatitisC","volume":"9","author":"Backus","year":"2011","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0180","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jhep.2004.12.031","article-title":"Estimating the impact of hepatitisC virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitisC","volume":"42","author":"Buti","year":"2005","journal-title":"J Hepatol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0185","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitisC and advanced hepatic fibrosis","volume":"308","author":"Van der Meer","year":"2012","journal-title":"JAMA."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0190","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jhep.2016.01.029","article-title":"Impact of direct acting antiviral therapy in patients with chronic hepatitisC and decompensated cirrhosis","volume":"64","author":"Foster","year":"2016","journal-title":"J Hepatol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0195","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1053\/j.gastro.2018.10.033","article-title":"What are the benefits of a sustained virologic response to direct-acting antiviral therapy for hepatitisC virus infection?","volume":"156","author":"Ioannou","year":"2019","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0200","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.25606","article-title":"A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitisC virus patients with cirrhosis","volume":"56","author":"D\u2019Ambrosio","year":"2012","journal-title":"Hepatology."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0205","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2014 2021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J Hepatol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0210","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1177\/2050640618786067","article-title":"Long-term changes in liver elasticity in hepatitisC virus-infected patients with sustained virologic response after treatment with direct-acting antivirals","volume":"6","author":"Pietsch","year":"2018","journal-title":"United European Gastroenterol J."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0215","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cgh.2017.04.038","article-title":"Magnitude and kinetics of decrease in liver stiffness after antiviral therapy in patients with chronic hepatitisC: A systematic review and meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0220","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.gastro.2016.09.009","article-title":"Eradication of hepatitisC virus infection in patients with cirrhosis reduces risk of liver and non-liver complications","volume":"152","author":"Nahon","year":"2017","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0225","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jhep.2020.08.006","article-title":"Hepatic benefits of HCV cure","volume":"73","author":"Calvaruso","year":"2020","journal-title":"J Hepatol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0230","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.cgh.2020.02.044","article-title":"Disease progression in patients with hepatitisC virus infection treated with direct-acting antiviral agents","volume":"18","author":"Mendizabal","year":"2020","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dld.2018.01.005","article-title":"Disease outcomes after DAA-induced SVR: Data from the resist-HCV cohort","volume":"50","author":"Calvaruso","year":"2018","journal-title":"Dig Liver Dis."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0240","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/gast.1997.v112.pm9024300","article-title":"Morbidity and mortality in compensated cirrhosis typeC: A retrospective follow-up study of 384 patients","volume":"112","author":"Fattovich","year":"1997","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0245","article-title":"Impact of hepatitisC virus genotype3 on liver disease progression in a Chinese national cohort","volume":"133","author":"Wu","year":"2020","journal-title":"Chin Med J (Engl)."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0250","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jhep.2016.10.028","article-title":"Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitisC in Canada","volume":"66","author":"Janjua","year":"2017","journal-title":"J Hepatol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0255","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.47.5.610","article-title":"Interferon therapy reduces the risk for hepatocellular carcinoma","volume":"47","author":"Brown","year":"2000","journal-title":"Gut."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0260","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.3748\/wjg.v26.i43.6770","article-title":"Hepatocellular carcinoma after direct-acting antiviral hepatitisC virus therapy: A debate near the end","volume":"26","author":"Muzica","year":"2020","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0265","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","article-title":"Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy","volume":"65","author":"Reig","year":"2016","journal-title":"J Hepatol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0270","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2016.06.015","article-title":"Early occurrence and recurrence of hepatocellular carcinoma in HCV related cirrhosis treated with direct-acting antivirals","volume":"65","author":"Conti","year":"2016","journal-title":"J Hepatol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0275","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jhep.2017.01.028","article-title":"Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype1 infection: Results from a Spanish real-world cohort","volume":"66","author":"Calleja","year":"2017","journal-title":"J Hepatol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0280","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1053\/j.gastro.2016.12.021","article-title":"Unusually high rates of hepatocellular carcinoma after treatment with direct-acting antiviral therapy for hepatitisC related cirrhosis","volume":"152","author":"Ravi","year":"2017","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0285","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitisC: Final update of the series","volume":"73","author":"Pawlotsky","year":"2020","journal-title":"J Hepatol."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0290","doi-asserted-by":"crossref","first-page":"e0233212","DOI":"10.1371\/journal.pone.0233212","article-title":"Impact of direct-acting antiviral therapy for hepatitisC-related hepatocellular carcinoma","volume":"15","author":"Lin","year":"2020","journal-title":"PLoS One."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0295","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1053\/j.gastro.2019.01.027","article-title":"Direct-acting antiviral therapy not associated with recurrence of hepatocellular carcinoma in a multicenter North American cohort study","volume":"156","author":"Singal","year":"2019","journal-title":"Gastroenterology."},{"key":"10.1016\/j.gastrohep.2022.02.002_bib0300","first-page":"293","article-title":"Decreased risk of hepatocellular carcinoma recurrence with direct-acting antivirals compared with no treatment for hepatitisC: A meta-analysis","volume":"33","author":"Lui","year":"2020","journal-title":"Ann Gastroenterol."}],"container-title":["Gastroenterolog\u00eda y Hepatolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570522000644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0210570522000644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:45:52Z","timestamp":1759322752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0210570522000644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S0210570522000644"],"URL":"https:\/\/doi.org\/10.1016\/j.gastrohep.2022.02.002","relation":{},"ISSN":["0210-5705"],"issn-type":[{"value":"0210-5705","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evoluci\u00f3n de los pacientes con infecci\u00f3n cr\u00f3nica por hepatitis C con fibrosis avanzada o cirrosis curados con antivirales de acci\u00f3n directa. Seguimiento a largo plazo","name":"articletitle","label":"Article Title"},{"value":"Gastroenterolog\u00eda y Hepatolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastrohep.2022.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}